Laszlo Mechtler, MD

PrintE-mail
Associate Professor
Chief, Department of Neuro-Oncology
Roswell Park Cancer Institute
Clinical Associate Professor of Neurology
School of Medicine and Biomedical Sciences, State University of New York at Buffalo
Vice President
Director, Brain Tumor Center
Director, Headache Clinic
Dent Neurologic Institute

Profile

Areas of Expertise: 
Brain cancer

Research

Research Interests: 
Diagnosis and treatment of malignant brain tumors
Neuroimaging
Headache and pain management

Background Information

Education and Training: 
MD - Semmelweiss University of Medicine, Budapest, Hungary
Residency: 
Dent Neurologic Institute, Buffalo, NY
State University of New York at Buffalo
Board Certification: 
Neurology, American Board of Psychiatry and Neurology
Neuroimaging, United Council for Neurologic Subspecialties
Neuro-Oncology, United Council for Neurologic Subspecialties
Headache, United Council for Neurologic Subspecialties
Fellowships: 
University of Texas MD Anderson Cancer Center, Houston, TX
Lucy Dent Imaging Center, Buffalo, NY

Publications

Publications: 
  • Tarnoki DL, Tarnoki AD, Hyland A, Travers MJ, Dobson K, Mechtler L, Cummings KM. Measurement of indoor smoke pollution in public places in Hungary [Zárt közösségi helyek dohányfüst-koncentrációjának mérése Magyarországon]. Orvosi hetilap 2010; 151(6):213-219
  • Mechtler L. Neuroimaging. Preface. Neurologic clinics 2009; 27(1):xiii-xiv
  • Tarnoki DL, Tarnoki AD, Travers MJ, Mechtler L, Tamas L, Cummings KM. Compliance still a problem with no smoking law. Tobacco control 2010; 19(6):520
  • Tárnoki AD, Tárnoki DL, Travers MJ, Hyland A, Dobson K, Mechtler L, Cummings KM. Tobacco smoke is a major source of indoor air pollution in Hungary’s bars, restaurants and transportation venues. Clinical and experimental medical journal 2009; 3(1):131-138

Cancer Can't Win

More patients are being diagnosed with cancer every day.

Here at Roswell Park Cancer Institute, we must continue to do what we do best – to understand, prevent and cure cancer. Because if we don’t, cancer wins. And Cancer Can’t Win.

  • With more than 3,000 scientific, academic and medical minds – Cancer Can’t Win.
  • When we are leading an advanced genetic program and creating next generation cancer vaccines to prevent it – Cancer Can’t Win.
  • When we are starting 13 new companies to advance our discoveries and share them with the world – Cancer Can’t Win.

Learn more about why Cancer Can’t Win

close